Early hemoglobin response to epoetin alfa is associated with significantly better clinical outcomes in breast cancer patients

被引：0
|
作者：
Lefevbre, P
Rosberg, J
Duh, MS
McKenzie, RS
Fastenau, J
Piech, CT
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Ortho Biotech Clin Affairs LLC, Bridgewater, NJ USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2004年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [41] Greater area under the hemoglobin change curve is associated with improved outcomes in patients receiving epoetin alfa (EPO) or darbepoetin alfa (DARB) for chemotherapy-related anemia (CRA).
    Lefebvre, P
    Duh, MS
    McKenzie, RS
    Mody, SH
    Woodman, RC
    Williams, D
    PHARMACOTHERAPY, 2005, 25 (10): : 1469 - 1469
  • [42] Aromatase inhibitors are significantly better tolerated by early stage breast cancer patients 75 or older and with significantly lower early discontinuation rate
    Chaudhry, B.
    Baer, L.
    Kudelka, A.
    Cohen, J.
    Stopeck, A. T.
    CANCER RESEARCH, 2019, 79 (04)
  • [43] Epoetin alfa treatment in anaemic gynaecological cancer patients: Haematological and quality of life (QOL) outcomes
    Taylor, C
    ANNALS OF ONCOLOGY, 1998, 9 : 68 - 68
  • [44] Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
    Matti S. Aapro
    David C. Dale
    Michael Blasi
    Brenda Sarokhan
    Fawzia Ahmed
    Richard C. Woodman
    Supportive Care in Cancer, 2006, 14 : 1184 - 1194
  • [45] Haematological and quality of life (QOL) outcomes in anaemic lung cancer patients treated with epoetin alfa
    Glaspy, J
    ANNALS OF ONCOLOGY, 1998, 9 : 142 - 142
  • [46] Influence of hemoglobin response to epoetin alfa on quality-of-life in anemic children with cancer receiving myelosuppressive chemotherapy.
    Razzouk, BI
    Hockenberry, M
    Hinds, PS
    Feusner, J
    Rackoff, W
    Hord, JD
    BLOOD, 2004, 104 (11) : 609A - 610A
  • [47] Epoetin alfa increases hemoglobin levels and improves quality of life in anemic geriatric cancer patients receiving chemotherapy
    Aapro, Matti S.
    Dale, David C.
    Blasi, Michael
    Sarokhan, Brenda
    Ahmed, Fawzia
    Woodman, Richard C.
    SUPPORTIVE CARE IN CANCER, 2006, 14 (12) : 1184 - 1194
  • [48] Annexin A7 is correlated with better clinical outcomes of patients with breast cancer
    Huang, Yuanli
    Wang, Hongo
    Yang, Yuanrong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (09) : 7577 - 7584
  • [49] Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
    Leyland-Jones, B
    Semiglazov, V
    Pawlicki, M
    Pienkowski, T
    Tjulandin, S
    Manikhas, G
    Makhson, A
    Roth, A
    Dodwell, D
    Baselga, J
    Biakhov, M
    Valuckas, K
    Voznyi, E
    Liu, XY
    Vercammen, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 5960 - 5972
  • [50] Epoetin alfa in the treatment of anemia in cancer patients receiving platinum chemotherapy: Response predicting factors
    Baron, MG
    Constenla, M
    Franquesa, R
    Montalar, J
    Gili, F
    Camps, C
    Cachot, P
    Ordonez, A
    Ozores, R
    Feyjoo, M
    ANNALS OF ONCOLOGY, 1998, 9 : 145 - 145
12345